Sunday, 16 June 2019

Drug Discovery News

  • China will overtake Japan in R&D spending: Report

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2013

    Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, investing billions of dollars and setting up innovation centers in a bid ...Read more

  • Astellas gets FDA nod for kidney transplant drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more

  • Global collaborations is the way forward for drug discovery

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more

  • NIH gives $2.2 mn to VaxInnate for dengue vaccine

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

    Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provided funds worth $2.2 million to US based-novel vaccine firm VaxInnate...Read more

  • Janssen to develop therapy for immunological diseases

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and commercialization, except in Japan, of ASP015K, an oral, small molecul...Read more

  • European Commission nod for Novartis' Exjade

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inade...Read more

  • CSL hemophilia therapy gets orphan drug status

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

  • John Vernachio is Arthritis Foundation research VP

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2013

    Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his new role he will provide leadership and direction to further the Arthr...Read more

  • FDA gets biomarker database license from GVK Bio

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification Group of the US FDA. The Gobiom database, which has the latest and re...Read more

  • Otsuka, Lundbeck files NDA for schizophrenia drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

  • NIH study: Diabetes drug Metformin extends life

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led...Read more

  • Accelerating drug discovery process

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

    In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platforms to develop new drugs. Many biotechnology researchers and entreprene...Read more

  • Boehringer to open $46 mn biologics plant in Shanghai

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer contract manufacturing to Chinese companies developing their own drugs....Read more

  • Recycled plastic can kill drug-resistant fungi

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research Almaden have discovered a new, potentially life-saving application f...Read more

  • Novartis liver cancer trial with Afinitor flops

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more

  • Oramed submits pre-IND for exenatide to FDA

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (pre-IND) meeting request to the US FDA for a US-based trial on its or...Read more

  • Aussie drug delivery firm raises $19.3 mn

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to institutional and sophisticated investors in Europe, USA, Asia and A...Read more

  • Bayer initiates Phase II/III trial of a new compound for Hemophilia A

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hem...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls